Efficacy of high-energy, focused ESWT in treatment of lumbar facet joint pain: a randomized sham-controlled trial

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F25%3A10498129" target="_blank" >RIV/00064203:_____/25:10498129 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/68407700:21460/25:00390008 RIV/00216208:11130/25:10498129

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=CTBRt.IVwQ" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=CTBRt.IVwQ</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1097/JS9.0000000000002538" target="_blank" >10.1097/JS9.0000000000002538</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Efficacy of high-energy, focused ESWT in treatment of lumbar facet joint pain: a randomized sham-controlled trial

Popis výsledku v původním jazyce

OBJECTIVE: Lumbar facet joints (FJ) are a common source of chronic low back pain (LBP). Focused extracorporeal shock wave therapy (ESWT) has demonstrated potential in the treatment of musculoskeletal disorders due to its deeper tissue penetration and safety profile. This study aimed to evaluate the efficacy and safety of ESWT in the management of lumbar facet joint pain. METHODS: A prospective, randomized, sham-controlled trial was conducted in 128 patients with chronic lumbar facet syndrome confirmed by medial branch block. Patients were randomized to receive either focused ESWT (Group A, n = 64; 0.35 mJ/mm2, 1200 shocks/session = 600 shocks per segment, 5 weekly sessions) or sham therapy (Group B, n = 64). Pain intensity (VAS), disability (ODI), and neuropathic pain features (PainDETECT questionnaire) were assessed at 2, 6, and 12 months. Lumbar spine MRI was performed at baseline and 6 months post-treatment. RESULTS: Group A showed significant reductions in VAS scores at 6 and 12 months (mean 64.4% reduction at 12 months, p&lt;0.01), with an effect size (Cohen&apos;s d = 1.12). ODI decreased by 42.3% in Group A compared to 12.5% in the sham group. Neuropathic pain symptoms improved significantly only in Group A (PD-Q reduction from 18.3 +- 2.4 to 10.2 +- 1.9; p&lt;0.01). MRI follow-up demonstrated resolution of bone marrow edema in 58.8% of ESWT-treated patients versus none in the control group. No adverse effects were reported. CONCLUSIONS: High-energy focused ESWT is a safe and effective non-invasive therapy for chronic lumbar facet joint pain, showing sustained improvements in pain, function, and neuropathic symptoms. MRI findings support its biological effect on joint-related bone marrow edema. ESWT represents a promising alternative to interventional pain procedures.

Název v anglickém jazyce

Efficacy of high-energy, focused ESWT in treatment of lumbar facet joint pain: a randomized sham-controlled trial

Popis výsledku anglicky

OBJECTIVE: Lumbar facet joints (FJ) are a common source of chronic low back pain (LBP). Focused extracorporeal shock wave therapy (ESWT) has demonstrated potential in the treatment of musculoskeletal disorders due to its deeper tissue penetration and safety profile. This study aimed to evaluate the efficacy and safety of ESWT in the management of lumbar facet joint pain. METHODS: A prospective, randomized, sham-controlled trial was conducted in 128 patients with chronic lumbar facet syndrome confirmed by medial branch block. Patients were randomized to receive either focused ESWT (Group A, n = 64; 0.35 mJ/mm2, 1200 shocks/session = 600 shocks per segment, 5 weekly sessions) or sham therapy (Group B, n = 64). Pain intensity (VAS), disability (ODI), and neuropathic pain features (PainDETECT questionnaire) were assessed at 2, 6, and 12 months. Lumbar spine MRI was performed at baseline and 6 months post-treatment. RESULTS: Group A showed significant reductions in VAS scores at 6 and 12 months (mean 64.4% reduction at 12 months, p&lt;0.01), with an effect size (Cohen&apos;s d = 1.12). ODI decreased by 42.3% in Group A compared to 12.5% in the sham group. Neuropathic pain symptoms improved significantly only in Group A (PD-Q reduction from 18.3 +- 2.4 to 10.2 +- 1.9; p&lt;0.01). MRI follow-up demonstrated resolution of bone marrow edema in 58.8% of ESWT-treated patients versus none in the control group. No adverse effects were reported. CONCLUSIONS: High-energy focused ESWT is a safe and effective non-invasive therapy for chronic lumbar facet joint pain, showing sustained improvements in pain, function, and neuropathic symptoms. MRI findings support its biological effect on joint-related bone marrow edema. ESWT represents a promising alternative to interventional pain procedures.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30306 - Sport and fitness sciences

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

International Journal of Surgery

ISSN

1743-9191

e-ISSN

1743-9159

Svazek periodika

111

Číslo periodika v rámci svazku

7

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

10

Strana od-do

4177-4186

Kód UT WoS článku

001530842000017

EID výsledku v databázi Scopus

2-s2.0-105013041876